Cancers, Free Full-Text

Neuroblastoma is the most common extracranial solid pediatric tumor, with around 15% childhood cancer-related mortality. High-risk neuroblastomas exhibit a range of genetic, morphological, and clinical heterogeneities, which add complexity to diagnosis and treatment with existing modalities. Identification of novel therapies is a high priority in high-risk neuroblastoma, and the combination of genetic analysis with increased mechanistic understanding—including identification of key signaling and developmental events—provides optimism for the future. This focused review highlights several recent findings concerning chromosomes 1p, 2p, and 11q, which link genetic aberrations with aberrant molecular signaling output. These novel molecular insights contribute important knowledge towards more effective treatment strategies for neuroblastoma.

Download or order free information booklets

Cancer Support Community

Working with Filters - My NCBI Help - NCBI Bookshelf

The Hallmarks of Cancer: Cell

Information and Resources about for Cancer: Breast, Colon, Lung, Prostate, Skin

ACS: 31,500 diagnosed with HPV cancers annually, most preventable with vaccine

Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer

Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers, Breast Cancer Research

I Am Cancer Free! - Cancer Free Gift - Pin

Hallmarks of Cancer: The Next Generation: Cell

The role of free-fatty acid receptor-4 (FFA4) in human cancers and cancer cell lines - ScienceDirect

What is cancer of unknown primary (CUP)?

Cancer Free – Heaven Sent Greeting Cards

Pathology Outlines - Carcinoma-general

Cancer Free Posters for Sale